MedTrace Logo

Changing Trunk Muscle Activation in Patients With Recurrent Low Back Pain in Remission

NCT06452030 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2024-06-11

No results posted yet for this study

Summary

The first aim of the study is to investigate the effects of a single therapy session on trunk muscle activation and lumbopelvic sensorimotor control in persons with recurrent low back pain in remission.

The second aim of the study is to examine the convergent validity of (in)voluntary multifidus activation by means of inspection and palpation during two clinically assessed lumbopelvic sensorimotor control tests in persons with recurrent low back pain in remission. The convergent validity will be examined by calculating the relationship between (1) the clinical score of (in)voluntary multifidus activation, (2) back muscle activation during the same tests measured simultaneously with electromyography and (3) trunk muscle activation during other functional movements measured with electromyography.

The third aim of the study is to investigate the convergent validity of a left-right discrimination test by calculating the relationship between (1) the left-right discrimination test, (2) position-reposition test, (3) the Fremantle Back Awareness Questionnaire and (4) the Photograph Series of Daily Activities Scale.

Conditions

  • Recurrent Low Back Pain
  • Remission

Interventions

BEHAVIORAL

Specific sensorimotor control training

Participants allocated to the specific motor control group will receive sensorimotor training of the multifidus muscle.

BEHAVIORAL

Aspecific extension training

Participants allocated to the aspecific group will receive spinal extension exercises.

BEHAVIORAL

Fascia training

Participants allocated to the fascia group will receive general movement exercises.

Sponsors & Collaborators

  • VZW Educatieve Lichaamsbeweging

    collaborator UNKNOWN

  • University Ghent

    lead OTHER

Principal Investigators

  • Lieven Danneels, Prof · University Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-29
Primary Completion
2025-10-01
Completion
2025-10-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06452030 on ClinicalTrials.gov